Global Healthcare-Acquired Infection Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 143975
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 121
  • list Pharmaceuticals and Healthcare

The healthcare-acquired infection is a new infection that develops in a patient during hospitalization.

Scope of the Report:

The global Healthcare-Acquired Infection market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Healthcare-Acquired Infection.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Healthcare-Acquired Infection market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Healthcare-Acquired Infection market by product type and applications/end industries.

Market Segment by Companies, this report covers

Pfizer

Novartis

Roche

Sanofi

Abbott

BD

Hologic

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pharmaceutical Treatment

Environment Treatment

Medical Devices Management

Market Segment by Applications, can be divided into

Hospital

Clinics

Ambulatory Surgery Centers

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Healthcare-Acquired Infection Market Overview

1.1 Product Overview and Scope of Healthcare-Acquired Infection

1.2 Classification of Healthcare-Acquired Infection by Types

1.2.1 Global Healthcare-Acquired Infection Revenue Comparison by Types (2019-2024)

1.2.2 Global Healthcare-Acquired Infection Revenue Market Share by Types in 2018

1.2.3 Pharmaceutical Treatment

1.2.4 Environment Treatment

1.2.5 Medical Devices Management

1.3 Global Healthcare-Acquired Infection Market by Application

1.3.1 Global Healthcare-Acquired Infection Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Ambulatory Surgery Centers

1.3.5 Others

1.4 Global Healthcare-Acquired Infection Market by Regions

1.4.1 Global Healthcare-Acquired Infection Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Healthcare-Acquired Infection Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Healthcare-Acquired Infection Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Healthcare-Acquired Infection Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Healthcare-Acquired Infection Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Healthcare-Acquired Infection Status and Prospect (2014-2024)

1.5 Global Market Size of Healthcare-Acquired Infection (2014-2024)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Healthcare-Acquired Infection Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2018)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Healthcare-Acquired Infection Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2018)

2.3 Roche

2.3.1 Business Overview

2.3.2 Healthcare-Acquired Infection Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Roche Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2018)

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Healthcare-Acquired Infection Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2018)

2.5 Abbott

2.5.1 Business Overview

2.5.2 Healthcare-Acquired Infection Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Abbott Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2018)

2.6 BD

2.6.1 Business Overview

2.6.2 Healthcare-Acquired Infection Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 BD Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2018)

2.7 Hologic

2.7.1 Business Overview

2.7.2 Healthcare-Acquired Infection Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Hologic Healthcare-Acquired Infection Revenue, Gross Margin and Market Share (2017-2018)

3 Global Healthcare-Acquired Infection Market Competition, by Players

3.1 Global Healthcare-Acquired Infection Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Healthcare-Acquired Infection Players Market Share

3.2.2 Top 10 Healthcare-Acquired Infection Players Market Share

3.3 Market Competition Trend

4 Global Healthcare-Acquired Infection Market Size by Regions

4.1 Global Healthcare-Acquired Infection Revenue and Market Share by Regions

4.2 North America Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

4.3 Europe Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

4.5 South America Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

5 North America Healthcare-Acquired Infection Revenue by Countries

5.1 North America Healthcare-Acquired Infection Revenue by Countries (2014-2019)

5.2 USA Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

5.3 Canada Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

5.4 Mexico Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

6 Europe Healthcare-Acquired Infection Revenue by Countries

6.1 Europe Healthcare-Acquired Infection Revenue by Countries (2014-2019)

6.2 Germany Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

6.3 UK Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

6.4 France Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

6.5 Russia Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

6.6 Italy Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Healthcare-Acquired Infection Revenue by Countries

7.1 Asia-Pacific Healthcare-Acquired Infection Revenue by Countries (2014-2019)

7.2 China Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

7.3 Japan Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

7.4 Korea Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

7.5 India Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

8 South America Healthcare-Acquired Infection Revenue by Countries

8.1 South America Healthcare-Acquired Infection Revenue by Countries (2014-2019)

8.2 Brazil Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

8.3 Argentina Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

8.4 Colombia Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Healthcare-Acquired Infection by Countries

9.1 Middle East and Africa Healthcare-Acquired Infection Revenue by Countries (2014-2019)

9.2 Saudi Arabia Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

9.3 UAE Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

9.4 Egypt Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

9.5 Nigeria Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

9.6 South Africa Healthcare-Acquired Infection Revenue and Growth Rate (2014-2019)

10 Global Healthcare-Acquired Infection Market Segment by Type

10.1 Global Healthcare-Acquired Infection Revenue and Market Share by Type (2014-2019)

10.2 Global Healthcare-Acquired Infection Market Forecast by Type (2019-2024)

10.3 Pharmaceutical Treatment Revenue Growth Rate (2014-2024)

10.4 Environment Treatment Revenue Growth Rate (2014-2024)

10.5 Medical Devices Management Revenue Growth Rate (2014-2024)

11 Global Healthcare-Acquired Infection Market Segment by Application

11.1 Global Healthcare-Acquired Infection Revenue Market Share by Application (2014-2019)

11.2 Healthcare-Acquired Infection Market Forecast by Application (2019-2024)

11.3 Hospital Revenue Growth (2014-2019)

11.4 Clinics Revenue Growth (2014-2019)

11.5 Ambulatory Surgery Centers Revenue Growth (2014-2019)

11.6 Others Revenue Growth (2014-2019)

12 Global Healthcare-Acquired Infection Market Size Forecast (2019-2024)

12.1 Global Healthcare-Acquired Infection Market Size Forecast (2019-2024)

12.2 Global Healthcare-Acquired Infection Market Forecast by Regions (2019-2024)

12.3 North America Healthcare-Acquired Infection Revenue Market Forecast (2019-2024)

12.4 Europe Healthcare-Acquired Infection Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Healthcare-Acquired Infection Revenue Market Forecast (2019-2024)

12.6 South America Healthcare-Acquired Infection Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Healthcare-Acquired Infection Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Healthcare-Acquired Infection Picture

Table Product Specifications of Healthcare-Acquired Infection

Table Global Healthcare-Acquired Infection and Revenue (Million U

Please fill the form below, to recieve the report sample


+1